334 related articles for article (PubMed ID: 31129709)
1. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
Gaetani L; Salvadori N; Lisetti V; Eusebi P; Mancini A; Gentili L; Borrelli A; Portaccio E; Sarchielli P; Blennow K; Zetterberg H; Parnetti L; Calabresi P; Di Filippo M
J Neurol; 2019 Sep; 266(9):2157-2163. PubMed ID: 31129709
[TBL] [Abstract][Full Text] [Related]
2. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J
Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388
[TBL] [Abstract][Full Text] [Related]
4. Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?
Kalatha T; Arnaoutoglou M; Koukoulidis T; Hatzifilippou E; Bouras E; Baloyannis S; Koutsouraki E
J Int Med Res; 2019 May; 47(5):2187-2198. PubMed ID: 30982375
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis.
Virgilio E; Vecchio D; Crespi I; Puricelli C; Barbero P; Galli G; Cantello R; Dianzani U; Comi C
J Neurol; 2022 Jun; 269(6):3249-3257. PubMed ID: 35088141
[TBL] [Abstract][Full Text] [Related]
7. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K
Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869
[TBL] [Abstract][Full Text] [Related]
8. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome.
van der Vuurst de Vries RM; Wong YYM; Mescheriakova JY; van Pelt ED; Runia TF; Jafari N; Siepman TA; Melief MJ; Wierenga-Wolf AF; van Luijn MM; Samijn JP; Neuteboom RF; Hintzen RQ
Mult Scler; 2019 Jun; 25(7):958-967. PubMed ID: 29774770
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
Gaetani L; Eusebi P; Mancini A; Gentili L; Borrelli A; Parnetti L; Calabresi P; Sarchielli P; Blennow K; Zetterberg H; Di Filippo M
Mult Scler Relat Disord; 2019 Oct; 35():228-232. PubMed ID: 31404762
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis.
Tortorella C; Direnzo V; Taurisano P; Romano R; Ruggieri M; Zoccolella S; Mastrapasqua M; Popolizio T; Blasi G; Bertolino A; Trojano M
Mult Scler; 2015 Apr; 21(4):396-401. PubMed ID: 25168208
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.
Quintana E; Coll C; Salavedra-Pont J; Muñoz-San Martín M; Robles-Cedeño R; Tomàs-Roig J; Buxó M; Matute-Blanch C; Villar LM; Montalban X; Comabella M; Perkal H; Gich J; Ramió-Torrentà L
Eur J Neurol; 2018 Sep; 25(9):1189-1191. PubMed ID: 29797629
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
Martin SJ; McGlasson S; Hunt D; Overell J
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1059-1067. PubMed ID: 31123141
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of CSF neurofilament light and heavy chain protein in MS.
Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
[TBL] [Abstract][Full Text] [Related]
14. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
Peng L; Bi C; Xia D; Mao L; Qian H
Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.
Lycke JN; Karlsson JE; Andersen O; Rosengren LE
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):402-4. PubMed ID: 9527161
[TBL] [Abstract][Full Text] [Related]
16. Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS.
Damasceno A; Dias-Carneiro RPC; Moraes AS; Boldrini VO; Quintiliano RPS; da Silva VAPG; Farias AS; Brandão CO; Damasceno BP; Dos Santos LMB; Cendes F
Mult Scler Relat Disord; 2019 May; 30():149-153. PubMed ID: 30772673
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament light chain in the assessment of patients with multiple sclerosis.
Domingues RB; Fernandes GBP; Leite FBVM; Senne C
Arq Neuropsiquiatr; 2019 Jul; 77(6):436-441. PubMed ID: 31314847
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and axonal injury in multiple sclerosis.
Sandberg L; Biström M; Salzer J; Vågberg M; Svenningsson A; Sundström P
Mult Scler; 2016 Jul; 22(8):1027-31. PubMed ID: 26462862
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis.
Edwards KR; Garten L; Button J; O'Connor J; Kamath V; Frazier C
Mult Scler Relat Disord; 2019 Jun; 31():59-61. PubMed ID: 30927733
[TBL] [Abstract][Full Text] [Related]
20. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
